BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.338
AS - Asia 3.860
EU - Europa 1.955
SA - Sud America 586
AF - Africa 101
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.194
SG - Singapore 1.169
HK - Hong Kong 809
CN - Cina 665
VN - Vietnam 450
BR - Brasile 423
GB - Regno Unito 350
IT - Italia 310
SE - Svezia 296
BD - Bangladesh 266
FI - Finlandia 261
RU - Federazione Russa 175
DE - Germania 118
KR - Corea 109
BG - Bulgaria 92
CA - Canada 77
FR - Francia 70
IN - India 67
AR - Argentina 64
NL - Olanda 46
IQ - Iraq 41
JP - Giappone 41
AE - Emirati Arabi Uniti 37
ID - Indonesia 37
ZA - Sudafrica 37
MX - Messico 33
PL - Polonia 31
UA - Ucraina 30
IE - Irlanda 28
TR - Turchia 27
AT - Austria 25
BE - Belgio 23
PK - Pakistan 23
CO - Colombia 22
ES - Italia 19
CL - Cile 18
EC - Ecuador 17
LT - Lituania 14
MY - Malesia 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
EG - Egitto 13
SA - Arabia Saudita 13
PY - Paraguay 12
KE - Kenya 10
UZ - Uzbekistan 10
IR - Iran 9
KZ - Kazakistan 9
MA - Marocco 9
IL - Israele 8
PH - Filippine 8
AZ - Azerbaigian 7
ET - Etiopia 7
JO - Giordania 7
NO - Norvegia 7
RO - Romania 7
UY - Uruguay 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
PE - Perù 6
TN - Tunisia 6
CH - Svizzera 5
DK - Danimarca 5
HN - Honduras 5
RS - Serbia 5
AU - Australia 4
BY - Bielorussia 4
GT - Guatemala 4
NP - Nepal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
LV - Lettonia 2
MK - Macedonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
CD - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DM - Dominica 1
GD - Grenada 1
Totale 13.833
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.159
Ashburn 862
Hong Kong 803
Singapore 765
Fairfield 552
Chandler 548
San Jose 289
Helsinki 255
Nyköping 255
London 220
Woodbridge 208
Houston 199
Wilmington 195
Seattle 166
Cambridge 159
Ann Arbor 148
Beijing 147
Ho Chi Minh City 139
Los Angeles 137
New York 136
Council Bluffs 123
Hanoi 116
The Dalles 116
San Diego 114
Seoul 108
Chicago 107
Sofia 91
Princeton 90
Hefei 60
Buffalo 59
Milan 56
Orem 53
Salt Lake City 50
Moscow 47
São Paulo 44
Southend 41
Shanghai 40
Dallas 38
Bremen 33
Jersey City 33
Tokyo 29
Dearborn 28
Da Nang 27
Dublin 26
Phoenix 26
Brussels 23
Johannesburg 23
Tampa 23
Toronto 23
Haiphong 22
Jakarta 22
Warsaw 22
Chennai 21
Redondo Beach 21
Rome 19
Frankfurt am Main 18
Amsterdam 17
San Francisco 17
Atlanta 15
Brooklyn 15
Bologna 14
Elk Grove Village 14
Miano 14
Rio de Janeiro 14
Groningen 13
Lauterbourg 13
Mexico City 13
Montreal 13
Paris 13
Vienna 13
Biên Hòa 12
Brno 12
Denver 12
Detroit 12
Manchester 12
Stockholm 12
Jacksonville 11
Norwalk 11
Falkenstein 10
Nairobi 10
Vancouver 10
Baghdad 9
Belo Horizonte 9
Buenos Aires 9
Charlotte 9
Curitiba 9
Kilburn 9
Modena 9
Newark 9
Nuremberg 9
Santiago 9
Sterling 9
Des Moines 8
Dhaka 8
Guangzhou 8
Santo André 8
Tashkent 8
Addis Ababa 7
Augusta 7
Dulles 7
Totale 9.616
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 364
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 316
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 306
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 286
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 274
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 255
Adaptive response in Hepatitis B virus infection 238
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 227
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 219
Alcohol and viral hepatitis: a mini-review 214
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 208
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 208
CD 133+ stem cells for the treatment of end stage liver disease 204
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 202
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 198
Chronic hepatitis B: Are we close to a cure? 195
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 189
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 187
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 182
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 179
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 178
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 178
Liver transplantation for patients with alcoholic liver disease: an open question 175
Stem cell mobilization and collection in patients with liver cirrhosis 175
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 174
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 172
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 165
MARS and Prometheus: our clinical experience in acute chronic liver failure 164
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 161
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 160
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 157
Bone marrow derived stem cells for the treatment of end-stage liver disease 157
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 156
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 156
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 156
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 156
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 155
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 154
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 154
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 152
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 151
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 151
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 150
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 148
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 145
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 145
Hepatitis B virus and immune response 142
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 142
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 142
Trattamento dell’epatopatia alcolica 141
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 140
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 139
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 136
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 134
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 134
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 133
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 132
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 130
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 130
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 129
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 128
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 128
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 127
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 125
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 125
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 124
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 122
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 120
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 116
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 113
Vitamins in the treatment of chronic viral hepatitis 111
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 111
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 110
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 110
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 109
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 108
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 106
Stem cells for end stage liver disease: How far have we got? 106
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 105
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 104
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 103
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 102
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 101
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 98
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 97
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 96
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 96
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 95
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 92
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 82
Totale 13.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/20221.484 257 134 48 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/20253.171 117 23 6 238 839 492 116 252 327 178 221 362
2025/20265.918 260 114 387 630 831 439 716 441 576 581 484 459
Totale 13.970